{"schema_version":"secwatch.filing_event.v1","accession":"0001386570-26-000035","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2026-06-29T20:30:40+00:00","discovered_at":"2026-06-29T20:32:00.459404+00:00","generated_at":"2026-06-29T20:32:12.466488+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Niagen Bioscience announces 2026 annual meeting voting results; all directors elected","bullets":["All 8 director nominees elected: Rubin (28.5M for, 16.8M withheld) and Shahbazi (30.5M for, 14.7M withheld) had significant withhold votes.","Ratification of Crowe LLP as auditor for fiscal 2026 passed with 56.2M for, 2.3M against, 158k abstain.","Advisory say-on-pay proposal approved with 43.2M for, 1.9M against, 172k abstain, and 13.3M broker non-votes.","Broker non-votes of 13.3M were recorded on director elections and say-on-pay but not on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0001386570-26-000035","json":"https://secwatch.observer/filing/0001386570-26-000035.json","markdown":"https://secwatch.observer/filing/0001386570-26-000035.md","text":"https://secwatch.observer/filing/0001386570-26-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000138657026000035/0001386570-26-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000138657026000035/cdxc-20260624.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T20:32:12.466488+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}